These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23526353)

  • 1. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
    Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
    Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
    Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
    Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
    Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
    J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
    Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
    Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
    Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
    FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma.
    Allam MM; Abd El Moneim E; Hassouna MM; El Jaky A; Zaghlah H
    Egypt J Immunol; 2009; 16(1):17-25. PubMed ID: 20726319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
    Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
    Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR1 and CCR5 promote hepatic fibrosis in mice.
    Seki E; De Minicis S; Gwak GY; Kluwe J; Inokuchi S; Bursill CA; Llovet JM; Brenner DA; Schwabe RF
    J Clin Invest; 2009 Jul; 119(7):1858-70. PubMed ID: 19603542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
    Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
    Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
    Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.
    Stoyanov E; Ludwig G; Mizrahi L; Olam D; Schnitzer-Perlman T; Tasika E; Sass G; Tiegs G; Jiang Y; Nie T; Kohler J; Schinazi RF; Vertino PM; Cedar H; Galun E; Goldenberg D
    Oncotarget; 2015 May; 6(13):11047-60. PubMed ID: 25918251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
    Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
    Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
    Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
    Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma].
    Kwon OS; Choi SH; Kim JH
    Korean J Gastroenterol; 2015 Dec; 66(6):320-4. PubMed ID: 26691189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.
    Zahavi T; Lanton T; Divon MS; Salmon A; Peretz T; Galun E; Axelrod JH; Sonnenblick A
    Oncotarget; 2016 Jan; 7(4):4860-70. PubMed ID: 26695439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.
    Ikenaga N; Liu SB; Sverdlov DY; Yoshida S; Nasser I; Ke Q; Kang PM; Popov Y
    Am J Pathol; 2015 Feb; 185(2):325-34. PubMed ID: 25478810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.
    Pham K; Luo D; Liu C; Harrison JK
    J Neuroimmunol; 2012 May; 246(1-2):10-7. PubMed ID: 22425022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.